About Urologix (OTCMKTS:ULGX)
21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Urologix (OTCMKTS:ULGX) Frequently Asked Questions
What is Urologix's stock symbol?
Urologix trades on the OTCMKTS under the ticker symbol "ULGX."
How were Urologix's earnings last quarter?
Urologix Inc. (OTCMKTS:ULGX) issued its earnings results on Thursday, February, 5th. The company reported ($0.02) EPS for the quarter. The business earned $3.10 million during the quarter, compared to the consensus estimate of $3.80 million. View Urologix's Earnings History.
Who are some of Urologix's key competitors?
Some companies that are related to Urologix include diaDexus (DDXS), NephroGenex (NRXGQ), School Specialty (SCHSQ), Local (LOCMQ), Kid Brands (KIDB), Circle Star Energy (CRCL), Body Central (BODY), Alco Stores (ALCSQ), New Western Energy (NWTR), ITT Educational Services (ESINQ), CTPartners Executive Search (CTPR), Alexza Pharmaceuticals (ALXA), Altice S A (ATCEY), ATP Oil & Gas (ATPAQ), BG Group (BRGYY), BPZ Resources (BPZRQ), Canadian Oil Sands (COSWF) and CARREFOUR SA UNSP/ADR (CRERY).
Who are Urologix's key executives?
Urologix's management team includes the folowing people:
- Gregory J. Fluet, Chief Executive Officer, Director (Age 45)
- Scott M Madson, Chief Financial Officer (Age 51)
- Lisa A. Ackermann, Executive Vice President - Sales and Marketing (Age 42)
- Mitchell Dann, Independent Non-Executive Chairman of the Board, Lead Director (Age 54)
- Christopher R. Barys, Independent Director (Age 48)
- Sidney W. Emery Jr., Independent Director (Age 70)
- Patrick D. Spangler, Independent Director (Age 59)
How do I buy Urologix stock?
Shares of Urologix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Urologix's stock price today?
One share of Urologix stock can currently be purchased for approximately $0.00.
How big of a company is Urologix?
Urologix has a market capitalization of $20,000.00.
How can I contact Urologix?
Urologix's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected]
MarketBeat Community Rating for Urologix (ULGX)MarketBeat's community ratings are surveys of what our community members think about Urologix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Urologix (OTCMKTS:ULGX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Urologix (OTCMKTS:ULGX) Earnings History and Estimates Chart
Urologix (OTCMKTS ULGX) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/5/2015||Q215||($0.02)||$3.80 million||$3.10 million||View||Listen|
|8/19/2014||Q4 14||($0.17)||$3.29 million||View||N/A|
|11/14/2012||Q113||($0.06)||($0.05)||$4.48 million||$4.00 million||View||N/A|
Urologix (OTCMKTS:ULGX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Urologix (OTCMKTS:ULGX)
No dividend announcements for this company have been tracked by MarketBeat.com
Urologix (OTCMKTS ULGX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 8.50%
Institutional Ownership Percentage: 0.28%
Urologix (OTCMKTS ULGX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/26/2013||Gregory Fluet||CEO||Buy||17,500||$0.31||$5,425.00|| |
|7/12/2013||Mitchell Dann||Director||Buy||20,000||$0.30||$6,000.00|| |
|7/10/2013||Gregory Fluet||CEO||Buy||25,000||$0.24||$6,000.00|| |
|7/9/2013||Lisa A Ackermann||EVP||Buy||18,500||$0.24||$4,440.00|| |
|7/8/2013||Gregory Fluet||CEO||Buy||66,400||$0.19||$12,616.00|| |
Urologix (OTCMKTS ULGX) News Headlines
Urologix (OTCMKTS:ULGX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Urologix (OTCMKTS:ULGX) Income Statement, Balance Sheet and Cash Flow Statement
Urologix (OTCMKTS ULGX) Stock Chart for Thursday, December, 14, 2017